Michael P. Murphy
Plus aucun poste en cours
Historique de carrière de Michael P. Murphy
Anciens postes connus de Michael P. Murphy
Sociétés | Poste | Début | Fin |
---|---|---|---|
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | Directeur des opérations | 05/11/2009 | 31/08/2011 |
LABCORP HOLDINGS INC. | Directeur/Membre du Conseil | 01/05/2005 | 01/05/2005 |
CompuLab Corp. | Corporate Officer/Principal | - | - |
Northern Light Eastern Maine Medical Center | Corporate Officer/Principal | - | - |
Formation de Michael P. Murphy
Xavier University | Undergraduate Degree |
The Ohio State University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Services | 2 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 4 |
---|---|
Laboratory Corp. of America Holdings
Laboratory Corp. of America Holdings Services to the Health IndustryHealth Services Laboratory Corp. of America Holdings operates as a life sciences company, which engages in the provision of vital information to help health professionals make clear and confident decisions. It operates through the Drug Development and Diagnostics segments. The Drug Development segment consists of lead optimization, preclinical safety assessment, analytical services, clinical trials, central laboratories, biomarkers, and companion diagnostics, market access, and technology solutions. The Diagnostics segment includes primary care, women's health, specialty medicine, oncology, ACOs, and hospitals and health systems. The company was founded in 1971 and is headquartered in Burlington, NC. | Health Services |
NorWesTech, Inc.
NorWesTech, Inc. Financial ConglomeratesFinance Norwes Tech, Inc. operates as a public shell company. The company previously provides biomarker laboratory services in the Drug Development Industry. It also provides specialty laboratory services to support pharmaceutical, biotechnology and diagnostic laboratory manufacturers in the conduct of human clinical research. The company offers clinical biomarker services for novel biomarkers, as well as custom assay services for pharmaceutical and biotechnology clients. It provides expert services in the areas of cardiovascular and musculoskeletal diseases, diabetes, obesity and nutrition. The company was founded by Elizabeth Leary and Russ Warnick in 1989 and is headquartered in Seattle, WA. | Finance |
Northern Light Eastern Maine Medical Center | |
CompuLab Corp. |
- Bourse
- Insiders
- Michael P. Murphy
- Expérience